Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Menopause. 2013 Sep;20(9):905–914. doi: 10.1097/GME.0b013e31828292d1

Figure 3.

Figure 3

Change in perceived sleep quality on the Pittsburgh Sleep Quality Index (PSQI) from before (“pre”) to 4 weeks on treatment (“post”) with the gonadotropin-releasing hormone agonist leuprolide in women who did and did not reported developing hot flashes (p=0.03). Increase in PSQI scores indicates worsening of perceived sleep quality.